Lauren Poole/LinkedIn
Jan 1, 2026, 00:01
NIH R35 Grant Supports Dr. Lauren Poole’s Research on Fibrinogen and Immune Responses
NIEHS P30 Center for Environmental Exposures and Diseases sharede a post on LinkedIn:
“Congratulations to CEED member Dr. Lauren Poole for her recently awarded R35 grant from NIH/NIGMS! Her team will study fibrinogen – an abundant plasma protein and acute phase reactant – and how it interacts with leukocytes to direct inflammatory responses and disease. They are using novel in vivo and in vitro approaches to understand the fundamental processes regulating the expression and pro-inflammatory functions of fibrinogen, laying the foundation for safe and specific therapies targeting fibrinogen.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
May 23, 2026, 03:55WFH Initiative Brings Hope to the Hemophilia Community in India
-
May 23, 2026, 03:47Satyam Arora: Welcoming the New ISBT Board for the 2026 Term
-
May 23, 2026, 03:33Brig Tathagata Chatterjee: Connecting With World Leaders in Hematology at ISH Congress
-
May 23, 2026, 03:18Mathangi Kumar: Dental Management Strategies for Congenital Hemophilia
-
May 23, 2026, 03:02Maitri Vaishnav: Anatomical Variability and Surgical Relevance of Corona Mortis
-
May 23, 2026, 02:26Muhammad Hashim: When the Blood Smear Told a Different Story Behind a ‘Critical’ Platelet Count
-
May 23, 2026, 02:20Augustina Isioma Ikusemoro: Understanding One of the Most Common and Preventable Transfusion Reactions
-
May 23, 2026, 02:15What’s Your Advice for the Newly Diagnosed? – ITP Support Association
-
May 23, 2026, 02:08Rob Maloney: When You Stop Building Only a Career and Start Building a Life of Significance